The FDA last week approved a DNA-based HPV test manufactured by Roche Molecular Systems as a primary screening option for cervical cancer. Called the “cobas HPV test,” the method detects DNA from high ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback